MacLean Michael F
Chief Financial Officer
MacLean Michael F has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including RNAM, RNA, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Feb 27, 2026.
On the most recent filing, MacLean Michael F is listed as Chief Financial Officer at Avidity Biosciences, Inc. Inside the rolling window, MacLean Michael F reported no open-market purchases and 2 open-market sales totaling $472K in RNA. The largest disclosed transaction in the window is a sale of 4,542 RNA shares on Jan 21, 2026, worth $329K.
Companies traded
Other insiders at RNAM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$472K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has MacLean Michael F made?
MacLean Michael F has filed 3 SEC Form 4 filings (4 transaction rows) across 2 companies, including RNAM, RNA since 2026.
Which companies does MacLean Michael F trade?
MacLean Michael F has filed SEC Form 4 disclosures for 2 companies, including RNAM, RNA.
When was MacLean Michael F's most recent SEC Form 4 filing?
MacLean Michael F's most recent SEC Form 4 filing on Tracefour is dated Feb 27, 2026.
What is MacLean Michael F's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, MacLean Michael F is listed as Chief Financial Officer.
What is MacLean Michael F's total buy and sell value in the current window?
Inside the rolling retention window, MacLean Michael F bought $0 and sold $472K based on SEC Form 4 filings.
What was MacLean Michael F's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,542 RNA shares on 2026-01-21, worth $329K, per SEC Form 4 filings.